Efficacy and tolerability of methotrexate therapy for refractory Crohn’s disease: a large single-centre experience
Version of Record online: 24 NOV 2011
© 2011 Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics
Volume 35, Issue 2, pages 284–291, January 2012
How to Cite
Suares, N. C., Hamlin, P. J., Greer, D. P., Warren, L., Clark, T. and Ford, A. C. (2012), Efficacy and tolerability of methotrexate therapy for refractory Crohn’s disease: a large single-centre experience. Alimentary Pharmacology & Therapeutics, 35: 284–291. doi: 10.1111/j.1365-2036.2011.04925.x
- Issue online: 15 DEC 2011
- Version of Record online: 24 NOV 2011
- Publication data Submitted 7 July 2011 First decision 1 August 2011 Resubmitted 1 November 2011 Accepted 2 November 2011 EV Pub Online 24 November 2011
Table S1. Univariate and multivariate analyses for response to methotrexate therapy at 4 months.
Table S2. Univariate and multivariate analyses for sustained clinical benefit with methotrexate therapy at last point of follow-up.
|APT_4925_sm_tableS1.doc||41K||Supporting info item|
|APT_4925_sm_tableS2.doc||38K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.